NEXT Virginia — Fairfax, Virginia

NEXT Virginia is a clinical research site located in Fairfax, Virginia, United States 22031.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

NEXT Virginia has participated in 88 clinical trials with 68 currently active.

Therapeutic areas: Advanced Solid Tumors, Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma.

Sponsors: Vividion Therapeutics, Inc., Bolt Biotherapeutics, Inc., Erasca, Inc..

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Virginia?

NEXT Virginia has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Virginia conducted?

NEXT Virginia has 88 clinical trials on record, with 68 currently active. Their work covers Advanced Solid Tumors, Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma.

Is NEXT Virginia accredited by Crixeo Health?

NEXT Virginia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Virginia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.